Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major
Arvind K Chavali1, Jeffrey D Whittemore1, James A Eddy1, Kyle T Williams1 & Jason A Papin1
- Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA
Correspondence to: Jason A Papin1 Department of Biomedical Engineering, University of Virginia, Box 800759, Health System, Charlottesville, VA 22908, USA. Tel.: +1 434 924 8195; Fax: +1 434 982 3870; Email: papin@virginia.edu
Received 19 November 2007; Accepted 6 February 2008; Published online 25 March 2008
Article highlights
- The Leishmania major metabolic network reconstruction iAC560 accounts for 560 genes, 1112 reactions, 1101 metabolites and 8 unique sub-cellular localizations.
- In a genome-scale in silico evaluation of gene knockouts, 12% of all single gene knockouts were found to be lethal and 10% were found to be growth-reducing. In addition, there were 56 non-trivial lethal double deletions.
- Predictions of gene essentiality were validated with published knockout studies. The in silico predictions were performed under four different medium conditions, namely: minimal medium; minimal medium and glucose; minimal medium, glucose and other amino acids; and defined medium. The minimal medium predictions had the greatest overall compliance with literature at 72.4% agreement.
- The reconstruction aided in providing functional annotation to 17 previously uncharacterized genes in the L. major genome. These genes were previously annotated as 'hypothetical proteins' in public databases.
- An in silico minimal medium composed of arginine, cysteine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine, hypoxanthine, phosphate and oxygen was predicted to support growth.
Synopsis
Computational modeling and systems analysis techniques can facilitate the interrogation of biological systems on the genome scale. Using available genomic, proteomic and metabolomic data, models of biochemical networks with predictive capabilities can be constructed (Forst, 2006). Computational analysis of these reconstructed networks can give much insight into the biological system and yield a set of hypotheses that can be experimentally validated.
The metabolic networks of several organisms, including Escherichia coli, Helicobacter pylori, Saccharomyces cerevisiae and Homo sapiens have been reconstructed, and the reconstructions of many others are currently underway (Schilling et al, 2002; Forster et al, 2003; Reed et al, 2003, 2006a; Borodina and Nielsen, 2005; Duarte et al, 2007; Feist et al, 2007; Oberhardt et al, 2008). These network models have facilitated the reconciliation of discrepancies between heterogeneous data sets (Reed et al, 2006a). Such systematic compilation has enabled precise characterization of cellular networks and aided in efforts to refine genome annotation (Feist et al, 2006; Reed et al, 2006a, 2006b). The resultant in silico models have predicted growth rates and gene essentiality under different medium conditions and have characterized the use of alternative carbon sources by particular organisms (Schilling et al, 2002; Feist et al, 2006, 2007).
Here, we report the reconstruction of the metabolic network of the parasite Leishmania major Friedlin, the causative agent of cutaneous leishmaniasis. Closely related Leishmania spp. cause diffuse cutaneous, mucocutaneous and visceral forms of the disease. Overall, leishmaniasis has an annual incidence rate of two million cases and causes approximately 59 000 deaths worldwide each year (Davies et al, 2003). This reconstruction and the associated network analyses represent the first constraint-based model for a protozoan. Among unicellular eukaryotes, Leishmania spp. are unique in their capacity for polycistronic transcription (Campbell et al, 2003), the presence of glycosome, acidocalcisome and flagellar compartments (Hart and Opperdoes, 1984; Opperdoes and Michels, 1993; de Souza, 2002; Docampo et al, 2005), their use of trypanothione as an analog of glutathione (Fairlamb et al, 1985), the occurrence of novel fatty acid synthesis mechanisms (Lee et al, 2007) and the presence of kinetoplast DNA (Simpson and Da Silva, 1971; Stuart, 1983).
The metabolic network reconstruction presented here accounts for 560 genes, 1112 reactions and 1101 metabolites. The reconstruction is highly compartmentalized with eight unique subcellular localizations accounted for in the model. We identified 12% of single gene knockouts in the network as lethal and 10% as growth reducing, and proposed 56 non-trivial lethal double deletions. Approximately 83% of all lethal single knockout genes belonged to three metabolic processes: lipid, carbohydrate or amino-acid metabolism, highlighting how critical these are to general function. Each one of these deletions constitutes a promising drug target and an experimentally testable hypothesis.
We validated the metabolic network with experimental knockout data from related Leishmania and Trypanosoma species. Table I lists the complete set of lethal and non-lethal knockouts obtained from literature and the corresponding in silico predictions in four different medium conditions, namely: minimal medium; minimal medium and glucose; minimal medium, glucose and other amino acids; and an additional defined medium (see Merlen et al (1999); Schuster and Sullivan (2002)). The rows colored gray, yellow and white indicate agreement with literature, partial agreement with literature and disagreement between model predictions and experimental data, respectively. In silico predictions in minimal medium had the best overall compliance with experimental data (72.4%). Predictions in minimal medium–glucose, minimal medium–glucose–other amino acids and defined medium had overall compliances of 69.0, 69.0 and 65.5%, respectively.
Through the network reconstruction and associated analyses, we demonstrated systematic refinement of genome annotation. A total of 17 out of 25 new annotation refinements were proposed for 'hypothetical proteins.' The rest of the proposed annotations were for genes that had an incorrect annotation, localization or EC classification. In addition, we proposed a novel in silico minimal medium that supports growth of L. major and evaluated growth response to non-essential components in defined medium. The in silico medium consisted of arginine, cysteine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine, hypoxanthine, phosphate and oxygen. The presence of hypoxanthine in the minimal medium highlighted the fact that L. major is unable to synthesize purines de novo (Berriman et al, 2005). If hypoxanthine is removed, AMP, dAMP, dGMP and GMP cannot be synthesized. Hypoxanthine, a purine derivative, fulfills the purine source requirement from the environment.
We provided two proof-of-concept examples yielding insight into the utility of network reconstruction and analysis. First, the robustness of the metabolic network was evaluated by varying the flux through mitochondrial F0F1-ATP synthase reaction (a target of oligomycin). By constraining the flux of the mitochondrial F0F1-ATP synthase reaction from its wild-type value to zero, the resulting effect on growth rate was calculated. Second, pathways differentially upregulated in the morphological stages of the parasite were identified by the use of protein expression data (see Figure 6). Differential protein expression data from Leishmania infantum suggested hexokinase was preferentially expressed in the amastigote stage, while alcohol dehydrogenase, enolase and ATP synthase were preferentially expressed in the promastigote stage (Leifso et al, 2007). Figure 6 depicts the reactions catalyzed by the differentially expressed enzymes. A red 'X' indicates that the flux through a particular reaction was reduced to 10% of its wild-type stage-independent value.
Figure 6
Reactions differentially expressed in amastigote or promastigote stages. The metabolic reactions that distinguish the morphological stages of L. major are highlighted. These include reactions catalyzed by hexokinase, ATP synthase, alcohol dehydrogenase and enolase. The red 'X' indicates that the flux through each reaction is reduced to 10% of its wild-type stage-independent flux value to characterize morphological stage-specific metabolism.
Full figure and legend (1,815K)Figures & Tables indexFinally, as an example of the model refinement process, we identified four gaps in the methionine salvage cycle and provided functional annotation to previously uncharacterized genes. Consequently, we improved our compliance of knockout predictions with experimental data from 51.7 to 65.5% agreement under defined medium conditions. The genome-scale metabolic reconstruction of L. major presented here provides a framework for the interrogation of human pathogens and a platform for integration of high-throughput data and generation of experimental hypotheses. These types of novel network analyses may be relevant to treating infectious diseases, particularly when diseases like leishmaniasis are considered emerging and uncontrolled, necessitating improvements in therapeutics and treatment strategies (Remme et al, 2002).
Acknowledgements
We acknowledge Erwin Gianchandani, Monica Lee, Kyle Singleton, Jennifer Reed, Natalie Duarte, Matthew Oberhardt, Corinne Locke, Jennifer Robichaux, Jong Min Lee, Richard Pearson and Fred Opperdoes for insightful comments and feedback. We also thank the National Science Foundation CAREER program (grant no. 0643548) for financial support.
References
- Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, Bartholomeu DC, Lennard NJ, Caler E, Hamlin NE, Haas B, Böhme U, Hannick L, Aslett MA, Shallom J, Marcello L, Hou L, Wickstead B, Alsmark UC, Arrowsmith C, Atkin RJ (2005) The genome of the African trypanosome Trypanosoma brucei. Science 309: 416–422 | Article | PubMed | ISI | ChemPort |
- Borodina I, Nielsen J (2005) From genomes to in silico cells via metabolic networks. Curr Opin Biotechnol 16: 350–355 | Article | PubMed | ISI | ChemPort |
- Campbell DA, Thomas S, Sturm NR (2003) Transcription in kinetoplastid protozoa: why be normal? Microbes Infect 5: 1231–1240 | Article | PubMed | ChemPort |
- Davies CR, Kaye P, Croft SL, Sundar S (2003) Leishmaniasis: new approaches to disease control. BMJ 326: 377–382 | Article | PubMed |
- de Souza W (2002) Special organelles of some pathogenic protozoa. Parasitol Res 88: 1013–1025 | Article | PubMed |
- Docampo R, de Souza W, Miranda K, Rohloff P, Moreno SN (2005) Acidocalcisomes—conserved from bacteria to man. Nat Rev Microbiol 3: 251–261 | Article | PubMed | ChemPort |
- Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srivas R, Palsson BO (2007) Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci USA 104: 1777–1782 | Article | PubMed | ChemPort |
- Fairlamb AH, Blackburn P, Ulrich P, Chait BT, Cerami A (1985) Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science 227: 1485–1487 | Article | PubMed | ISI | ChemPort |
- Feist AM, Henry CS, Reed JL, Krummenacker M, Joyce AR, Karp PD, Broadbelt LJ, Hatzimanikatis V, Palsson BO (2007) A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol Syst Biol 3: 121 | Article | PubMed | ChemPort |
- Feist AM, Scholten JC, Palsson BO, Brockman FJ, Ideker T (2006) Modeling methanogenesis with a genome-scale metabolic reconstruction of Methanosarcina barkeri. Mol Syst Biol 2: 2006.0004
- Forst CV (2006) Host–pathogen systems biology. Drug Discov Today 11: 220–227 | Article | PubMed | ChemPort |
- Forster J, Famili I, Fu P, Palsson BO, Nielsen J (2003) Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res 13: 244–253 | Article | PubMed | ISI | ChemPort |
- Hart DT, Opperdoes FR (1984) The occurrence of glycosomes (microbodies) in the promastigote stage of four major Leishmania species. Mol Biochem Parasitol 13: 159–172 | Article | PubMed | ChemPort |
- Lee SH, Stephens JL, Englund PT (2007) A fatty-acid synthesis mechanism specialized for parasitism. Nat Rev Microbiol 5: 287–297 | Article | PubMed | ChemPort |
- Leifso K, Cohen-Freue G, Dogra N, Murray A, McMaster WR (2007) Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: the Leishmania genome is constitutively expressed. Mol Biochem Parasitol 152: 35–46 | Article | PubMed | ChemPort |
- Merlen T, Sereno D, Brajon N, Rostand F, Lemesre JL (1999) Leishmania spp: completely defined medium without serum and macromolecules (CDM/LP) for the continuous in vitro cultivation of infective promastigote forms. Am J Trop Med Hyg 60: 41–50 | PubMed | ChemPort |
- Oberhardt MA, Puchalka J, Fryer KE, Dos Santos VA, Papin JA (2008) Genome-scale metabolic network analysis of the opportunistic pathogen Pseudomonas aeruginosa PAO1. J Bacteriol 8 (in press)
- Opperdoes FR, Michels PA (1993) The glycosomes of the Kinetoplastida. Biochimie 75: 231–234 | Article | PubMed | ChemPort |
- Reed JL, Famili I, Thiele I, Palsson BO (2006a) Towards multidimensional genome annotation. Nat Rev Genet 7: 130–141 | Article | PubMed | ISI | ChemPort |
- Reed JL, Patel TR, Chen KH, Joyce AR, Applebee MK, Herring CD, Bui OT, Knight EM, Fong SS, Palsson BO (2006b) Systems approach to refining genome annotation. Proc Natl Acad Sci USA 103: 17480–17484 | Article | PubMed | ChemPort |
- Reed JL, Vo TD, Schilling CH, Palsson BO (2003) An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol 4: R54 | Article | PubMed |
- Remme JH, Blas E, Chitsulo L, Desjeux PM, Engers HD, Kanyok TP, Kengeya Kayondo JF, Kioy DW, Kumaraswami V, Lazdins JK, Nunn PP, Oduola A, Ridley RG, Toure YT, Zicker F, Morel CM (2002) Strategic emphases for tropical diseases research: a TDR perspective. Trends Parasitol 18: 421–426 | Article | PubMed | ISI |
- Schilling CH, Covert MW, Famili I, Church GM, Edwards JS, Palsson BO (2002) Genome-scale metabolic model of Helicobacter pylori 26695. J Bacteriol 184: 4582–4593 | Article | PubMed | ISI | ChemPort |
- Schuster FL, Sullivan JJ (2002) Cultivation of clinically significant hemoflagellates. Clin Microbiol Rev 15: 374–389 | Article | PubMed |
- Simpson L, Da Silva A (1971) Isolation and characterization of kinetoplast DNA from Leishmania tarentolae. J Mol Biol 56: 443–473 | Article | PubMed | ChemPort |
- Stuart K (1983) Kinetoplast DNA, mitochondrial DNA with a difference. Mol Biochem Parasitol 9: 93–104 | Article | PubMed | ChemPort |


